IU School of Medicine to break ground on new, $230M home
Indiana University School of Medicine’s planned medical education and research building marks the largest construction project in the history of the school.
John Russell
Articles
Lilly to acquire Boston-based gene therapy firm for $487M
The Indianapolis-based drugmaker said it has reached a definitive agreement to acquire Akouos Inc., a seven-year-old biotech firm, which is running early clinical trials for its lead therapy for hearing loss.
Suit accuses Lilly of illegally deducting funds from paychecks for vehicle use, extra time off
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
Citizens, CenterPoint predict rise in winter heating bills
Utilities Citizens Energy Group and CenterPoint Energy said natural gas prices, which spiked a year ago, will be even higher this winter, leading to costlier heating bills in Indiana.
Roche executive sues company for discrimination after losing job in restructuring
Brigitte Fernandes is suing Roche for sex discrimination and national origin discrimination. A Roche spokesman declined to comment, citing pending litigation.
AES Indiana, customers at odds over $41M in costs incurred while power plant was down
The utility is asking for permission to pass on the cost of power it had to purchase from the grid during the outage, but customers are objecting.
New law clamps down on certain medical titles in advertising
Some say doctors are raising the issue just to protect their turf and status.
Indianapolis biotech trying to fight cancer navigates bumpy road
Point Biopharma is moving aggressively to get its lead drug, a radioactive isotope called lutetium 177, through late-stage trials for prostate cancer.
IU medical school wins $49M grant to continue Alzheimer’s studies
The money will be used to study animal models of late-onset Alzheimer’s disease as well as perform rigorous testing of potential therapeutics in animals.
Purdue project to develop treatment for deadly brain cancer wins $398,000 in federal funding
Three Indiana institutions are teaming up to try to develop a treatment for glioblastoma, a lethal cancer that begins with the brain or spinal cord, and is difficult to treat, often requiring a combination of surgery, chemotherapy and radiation.
Q&A: Career path jumps from megacorp to small not-for-profit
Michele Sawyer started Sept. 1 as chief financial officer at the Indiana Biosciences Research Institute after more than two decades at drugmaker Eli Lilly and Co. and its animal health spinoff, Elanco Animal Health.
In unhealthy Indiana, business and health leaders rally around plan to boost public health spending
A blue-ribbon commission appointed by Gov. Eric Holcomb is recommending that the state spend an additional $242 million a year to help local health departments and school districts make their communities healthier.
New York-based Cityblock Health expanding into Indiana, plans 140 new jobs
Brooklyn-based Cityblock Health Inc. and Indianapolis-based health maintenance organization MDwise Inc. said their partnership would bring care to about 10,000 people in Indianapolis and Fort Wayne.
Colorado senior-care company pauses expansion into Indiana after Medicare audit
InnovAge Holding Corp. had planned to offer services in Terre Haute starting in 2024, with a goal to enroll more than 600 seniors.
Tensions boil between ER docs, insurers as no-surprises law rolls out
The federal No Surprises Act—which took effect Jan. 1 and protects patients from receiving surprise medical bills resulting from unexpected, out-of-network coverage—is already creating huge waves.
Point Biopharma shares sink after pricing new stock offering at discount
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
Elanco’s new HQ project nearing city approval, with a few issues outstanding
The Greenfield-based company will lay out the design for its $100 million-plus global headquarters in Indianapolis on Thursday before a hearing examiner, who will rule on the project.
Damien Center launches $4M capital campaign to help fund new HQ
The not-for-profit organization said it has outgrown its existing 15,000-square-foot headquarters building at 26 N. Arsenal Ave. due to heavy demand for its services and programs.
A year later, fight continues over vaccine mandates
In recent months, current and former employees of drugmaker Eli Lilly and Co., medical-equipment maker Roche Diagnostics and health care system Ascension St. Vincent have filed suit in federal district court, claiming their religious views and civil liberties were violated.
Activists call on AES Indiana to retire coal-fired Petersburg plant
The largest and dirtiest power plant in AES Indiana’s fleet is coming under renewed criticism for violating its air and water permits and for maintenance problems that have contributed to higher customer bills.